Ozempic for prediabetes and high blood pressure and Ozempic cover how these conditions intersect with GLP-1 treatment
BPC-157, 15 (Gly, Glu, Pro, Pro, Pro, Gly, Lys, Pro, Ala, Asp, Asp, Ala, Gly, Leu, Val)
Yes, as long as you can handle lactose
This means the side effect profiles differ , the dosing schedules differ , and the weight loss outcomes differ
However, the cost of Wegovy can be a significant factor for patients to consider
New Trial Results STEP-HFpEF DM published in NEJM today Semaglutide improved heart failure symptoms and physical limitations in patients with obesity, HFpEF and Type 2 Diabetes 6.4% weight over placebo CRP 6 min walk distance These results are consistent with findings of a prior trial of semaglutide in HFpEF and obesity without type 2 diabetes